STAT5B-phosphorylation has been linked to poor survival in GBM, and in an EGFRvIII-driven GBM mouse model SFK mediated STAT5B activation regulates expression of AURKA and BCL2L1 [28], expression of both is induced by DEXA. The gene discussed is AURKA; the disease is glioblastoma.